H1B Report
Side-by-side comparison

GlaxoSmithKline LLC vs TATA CONSULTANCY SERVICES LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
GlaxoSmithKline LLC
PARank #FEIN 23-1099050
Entity B
TATA CONSULTANCY SERVICES LIMITED
MDRank #3FEIN 98-0429806

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricGlaxoSmithKline LLCTATA CONSULTANCY SERVICES LIMITED
Total filings733128,379
Certified %83.22%99.22%
Denied %0.41%0.15%
Withdrawn %2.05%0.50%
Cert-withdrawn %14.32%0.13%
Rank#3
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePAMD

Outcomes — GlaxoSmithKline LLC

DOL case-status mix.

Outcome breakdown: Certified 83.2%, Cert-withdrawn 14.3%, Withdrawn 2.1%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified83.2%
Cert-withdrawn14.3%
Withdrawn2.1%
Denied0.4%
Certified83.2%
Cert-withdrawn14.3%
Withdrawn2.1%
Denied0.4%

Outcomes — TATA CONSULTANCY SERVICES LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.2%, Cert-withdrawn 0.1%, Withdrawn 0.5%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

GlaxoSmithKline LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201023
FY201135
FY201248
FY201330
FY201424
FY201547
FY201660
FY201754
FY201855
FY201986
FY202031
FY202140
FY202217
FY202338
FY202459
FY202550
FY202636
TATA CONSULTANCY SERVICES LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,008
FY20115,386
FY20126,700
FY20138,724
FY201413,977
FY201516,514
FY201613,100
FY201713,511
FY201814,583
FY201911,853
FY202023
FY202115
FY202211
FY20232,459
FY20249,708
FY20257,886
FY20262,921

Top 5 occupations — GlaxoSmithKline LLC

Top 5 occupations — TATA CONSULTANCY SERVICES LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.